IL73972A0 - Agents based on platinum compounds - Google Patents

Agents based on platinum compounds

Info

Publication number
IL73972A0
IL73972A0 IL73972A IL7397284A IL73972A0 IL 73972 A0 IL73972 A0 IL 73972A0 IL 73972 A IL73972 A IL 73972A IL 7397284 A IL7397284 A IL 7397284A IL 73972 A0 IL73972 A0 IL 73972A0
Authority
IL
Israel
Prior art keywords
platinum compounds
agents based
agents
platinum
compounds
Prior art date
Application number
IL73972A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL73972A priority Critical patent/IL73972A0/xx
Publication of IL73972A0 publication Critical patent/IL73972A0/xx
Priority to AU51736/85A priority patent/AU5173685A/en
Priority to EP85116663A priority patent/EP0190464A3/de
Priority to DE198585116663T priority patent/DE190464T1/de
Priority to JP61000138A priority patent/JPS61222927A/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Peptides Or Proteins (AREA)
IL73972A 1984-12-31 1984-12-31 Agents based on platinum compounds IL73972A0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IL73972A IL73972A0 (en) 1984-12-31 1984-12-31 Agents based on platinum compounds
AU51736/85A AU5173685A (en) 1984-12-31 1985-12-30 Platinum-macromolecular carrier complexes
EP85116663A EP0190464A3 (de) 1984-12-31 1985-12-31 Krebsmittel
DE198585116663T DE190464T1 (de) 1984-12-31 1985-12-31 Krebsmittel.
JP61000138A JPS61222927A (ja) 1984-12-31 1986-01-04 白金化合物および医薬組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL73972A IL73972A0 (en) 1984-12-31 1984-12-31 Agents based on platinum compounds

Publications (1)

Publication Number Publication Date
IL73972A0 true IL73972A0 (en) 1985-03-31

Family

ID=11055578

Family Applications (1)

Application Number Title Priority Date Filing Date
IL73972A IL73972A0 (en) 1984-12-31 1984-12-31 Agents based on platinum compounds

Country Status (5)

Country Link
EP (1) EP0190464A3 (de)
JP (1) JPS61222927A (de)
AU (1) AU5173685A (de)
DE (1) DE190464T1 (de)
IL (1) IL73972A0 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100877A (en) * 1986-05-21 1992-03-31 Kuraray Co., Ltd. Platinum containing pullulan derivatives and pharmaceutical compositions comprising the same
WO1987007142A1 (fr) * 1986-05-21 1987-12-03 Kuraray Co., Ltd. Nouveaux complexes, procede pour leur preparation, et leur emploi medicinal
US4793986A (en) * 1987-02-25 1988-12-27 Johnson Matthey, Inc. Macromolecular platinum antitumor compounds
EP0307827A3 (de) * 1987-09-15 1989-12-27 Kuraray Co., Ltd. Makromolekulare Komplexe, ihre Herstellung und Verwendung in der Medizin
US4931553A (en) * 1988-05-11 1990-06-05 Gill Devinder S Platinum-polymer complexes and their use as antitumor agents
US5260050A (en) * 1988-09-29 1993-11-09 Ranney David F Methods and compositions for magnetic resonance imaging comprising superparamagnetic ferromagnetically coupled chromium complexes
EP0361960A3 (de) * 1988-09-29 1992-01-02 RANNEY, David F. Verfahren und Vorrichtung zur Bilderzeugung mittels magnetischer Resonanz
JPH0784481B2 (ja) * 1991-02-21 1995-09-13 株式会社デイ・デイ・エス研究所 カルボキシメチルマンノグルカン及びその誘導体
WO1995000177A1 (en) * 1993-06-17 1995-01-05 Dextran Products Limited Pharmaceutical preparation and a method for inhibiting the replication of various viruses
WO1998047496A2 (en) * 1997-04-18 1998-10-29 Access Pharmaceuticals, Inc. Polymer-platinum compounds
US5965118A (en) * 1997-04-18 1999-10-12 Access Pharmaceuticals, Inc. Polymer-platinum compounds
IL121084A0 (en) * 1997-06-15 1997-11-20 Yeda Res & Dev Compositions and methods for diagnosis of tumors by X-ray imaging
WO2010087976A2 (en) * 2009-01-31 2010-08-05 Igf Oncology, Llc Anti-cancer protein-platinum conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1541436A (en) * 1976-02-02 1979-02-28 Searle & Co Immunological materials
US4584392A (en) * 1982-11-10 1986-04-22 Inco Alloys International, Inc. Platinum and palladium complexes

Also Published As

Publication number Publication date
EP0190464A2 (de) 1986-08-13
JPS61222927A (ja) 1986-10-03
EP0190464A3 (de) 1987-02-04
AU5173685A (en) 1986-07-10
DE190464T1 (de) 1987-03-19

Similar Documents

Publication Publication Date Title
GB8614549D0 (en) Contrast agents
GB8613493D0 (en) Diester-dtpa-paramagnetic contrast agents
IL90300A0 (en) Substituted aminobenzonitriles
EP0150447A3 (en) Substituted dihydrobenzopyran-2-carboxylates
DE3574251D1 (en) An anti-amnestic agent
GB2160187B (en) Chemical oxygen-generator
GB8502806D0 (en) Microtome
IL73972A0 (en) Agents based on platinum compounds
ZA858385B (en) Fibrinolysis-enhancing agents
ZA859582B (en) Platinum complexes
AU95743S (en) Telelphone set
GB8521525D0 (en) Platinum
ZA856582B (en) Substituted carbonylphenylsulphonylguanidines
ZA854165B (en) Substituted phenylsuphonylureas
ZA854363B (en) Chemical oxygen-generator
ZA856592B (en) Substituted arylsulphonylguanidines
GB8415105D0 (en) Sealing-curing agent
GB8529238D0 (en) Agents
ZA856410B (en) Pest-combating agents containing phosphorus-heterocylic compounds
GB8503156D0 (en) Providing reference
GB2192884B (en) Substituted ethanediimidamides
ZA856889B (en) Platinum complexes
PH21368A (en) Fungicidal agents based on phosphoryloximinoacetamides
CS304784A1 (en) Zajistovaci ustroji soukaci hlavice viceproslupniho tkaciho stroje v manipulacni poloze
BG46062A1 (en) Zinc- (n- vinyloxyethyldithiocarbamate)